Rani Therapeutics Holdings, Inc.
RANI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001856725
In the last 90 days, Rani Therapeutics Holdings, Inc. insiders filed 2 open-market purchases and 2 sales; 68 institutions reported holding it in 13F filings for Q2 2026, worth $34.7M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Rani Therapeutics Holdings, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 34
- −3 vs. Q1 2024
- Shares held
- 3.11M
- −345.3K (−10.0%) vs. Q1 2024
- Total value
- $11.8M
- +$1.07M (+9.9%) vs. Q1 2024
- New holders
- 3
- 10 more added
- Sold out
- 6
- 7 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RANI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 68 | $34.7M |
| Q1 2026 | 74 | $31.4M |
| Q4 2025 | 64 | $60.5M |
| Q3 2025 | 38 | $2.02M |
| Q2 2025 | 39 | $3.32M |
| Q1 2025 | 38 | $4.58M |
| Q4 2024 | 42 | $5.23M |
| Q3 2024 | 31 | $12.8M |
| Q2 2024 | 34 | $11.8M |
| Q1 2024 | 37 | $10.7M |
| Q4 2023 | 34 | $10.9M |
| Q3 2023 | 34 | $6.96M |
| Q2 2023 | 35 | $13.3M |
| Q1 2023 | 36 | $15.5M |
| Q4 2022 | 34 | $17.6M |
| Q3 2022 | 32 | $30.4M |
| Q2 2022 | 28 | $29.1M |
| Q1 2022 | 24 | $34.5M |
| Q4 2021 | 22 | $20.3M |
| Q3 2021 | 15 | $19.6M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Rani Therapeutics Holdings, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 709,828 | $2.70M | 0.00% | +24,525+3.6% | Added |
| Nan Fung Group Holdings Ltd | 493,584 | $1.88M | 2.00% | 00.0% | Unchanged |
| Alphabet Inc. | 448,492 | $1.70M | 0.09% | 00.0% | Unchanged |
| United Services Automobile Association | 312,095 | $1.19M | 0.03% | −169,205−35.2% | Reduced |
| Takeda Pharmaceutical Co Ltd | 215,172 | $817.7K | 0.35% | −123,507−36.5% | Reduced |
| Geode Capital Management, LLC | 150,734 | $572.9K | 0.00% | +19,828+15.1% | Added |
| Stifel Financial Corp | 134,620 | $511.6K | 0.00% | +2,186+1.7% | Added |
| Bank of America Corp | 91,846 | $349.0K | 0.00% | −32,659−26.2% | Reduced |
| Bridgeway Capital Management, LLC | 71,500 | $271.7K | 0.01% | +20,000+38.8% | Added |
| BlackRock Inc. | 63,583 | $241.6K | 0.00% | 00.0% | Unchanged |
| Lasry Marc | 62,887 | $239.0K | 0.24% | 00.0% | Unchanged |
| King Luther Capital Management Corp | 56,129 | $213.3K | 0.00% | 00.0% | Unchanged |
| Motco | 48,129 | $182.9K | 0.01% | 00.0% | Unchanged |
| State Street Corp | 42,042 | $159.8K | 0.00% | +8,300+24.6% | Added |
| Northern Trust Corp | 35,306 | $134.2K | 0.00% | +9,318+35.9% | Added |
| Brown Advisory Inc | 32,911 | $125.1K | 0.00% | −1,000−2.9% | Reduced |
| Renaissance Technologies LLC | 21,700 | $82.5K | 0.00% | −48,600−69.1% | Reduced |
| Marshall Wace, LLP | 21,247 | $80.7K | 0.00% | +21,247 | New |
| Lafayette Investments, Inc. | 19,893 | $75.6K | 0.02% | 00.0% | Unchanged |
| Citadel Advisors LLC | 14,765 | $56.1K | 0.00% | +4,733+47.2% | Added |
| Tower Research Capital LLC (TRC) | 14,437 | $54.9K | 0.00% | +13,198+1,065.2% | Added |
| Prime Capital Investment Advisors, LLC | 13,882 | $52.8K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 10,153 | $39.0K | 0.00% | +10,153 | New |
| Islay Capital Management, LLC | 9,611 | $36.5K | 0.03% | 00.0% | Unchanged |
| UBS Group AG | 3,000 | $11.4K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 2,951 | $11.2K | 0.00% | +500+20.4% | Added |
| Allworth Financial LP | 3,119 | $9.61K | 0.00% | 00.0% | Unchanged |
| The PNC Financial Services Group, Inc. | 2,000 | $7.60K | 0.00% | −7,116−78.1% | Reduced |
| Simplex Trading, LLC | 1,482 | $5.00K | 0.00% | +118+8.7% | Added |
| Belvedere Trading LLC | 991 | $3.77K | 0.00% | +991 | New |
| Rhumbline Advisers | 312 | $1.19K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 71 | $270 | 0.00% | −12,615−99.4% | Reduced |
| Qube Research & Technologies Ltd | 3 | $12 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 12 | $0 | 0.00% | 00.0% | Unchanged |
| Activest Wealth Management | 0 | $0 | 0.00% | −9,800−100.0% | Sold out |
| Alpha Square Group S, LLC | 0 | $0 | 0.00% | −33,401−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −22,587−100.0% | Sold out |
| RSM US Wealth Management LLC | 0 | $0 | 0.00% | −19,813−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −103−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −39−100.0% | Sold out |